773 related articles for article (PubMed ID: 34790199)
1. Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis.
Meier UC; Cipian RC; Karimi A; Ramasamy R; Middeldorp JM
Front Immunol; 2021; 12():757302. PubMed ID: 34790199
[TBL] [Abstract][Full Text] [Related]
2. HLA DR2b-binding peptides from human endogenous retrovirus envelope, Epstein-Barr virus and brain proteins in the context of molecular mimicry in multiple sclerosis.
Ramasamy R; Mohammed F; Meier UC
Immunol Lett; 2020 Jan; 217():15-24. PubMed ID: 31689443
[TBL] [Abstract][Full Text] [Related]
3. Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression.
Pérez-Pérez S; Domínguez-Mozo MI; García-Martínez MÁ; García-Frontini MC; Villarrubia N; Costa-Frossard L; Villar LM; Arroyo R; Álvarez-Lafuente R
Front Immunol; 2021; 12():798003. PubMed ID: 34912348
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis: an example of pathogenic viral interaction?
Fierz W
Virol J; 2017 Feb; 14(1):42. PubMed ID: 28241767
[TBL] [Abstract][Full Text] [Related]
5. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis.
Mameli G; Poddighe L; Mei A; Uleri E; Sotgiu S; Serra C; Manetti R; Dolei A
PLoS One; 2012; 7(9):e44991. PubMed ID: 23028727
[TBL] [Abstract][Full Text] [Related]
6. Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis?
Mameli G; Madeddu G; Mei A; Uleri E; Poddighe L; Delogu LG; Maida I; Babudieri S; Serra C; Manetti R; Mura MS; Dolei A
PLoS One; 2013; 8(11):e78474. PubMed ID: 24236019
[TBL] [Abstract][Full Text] [Related]
7. Evolution of antibody titres against Epstein-Barr virus and human herpesvirus 6A/B and expression of multiple sclerosis-associated retrovirus in the serum of pregnant multiple sclerosis patients.
Pérez-Pérez S; Cuello JP; Martínez-Ginés M; Pardo-Rodríguez B; García-Domínguez JM; Domínguez-Mozo MI; Lozano-Ros A; García-Martínez MÁ; Higueras Y; Meldaña-Rivera A; Goicochea-Briceño H; Tejeda-Velarde A; Fernández-Velasco JI; Medina S; Arroyo R; Villar LM; Álvarez-Lafuente R
Sci Rep; 2021 Apr; 11(1):8441. PubMed ID: 33875702
[TBL] [Abstract][Full Text] [Related]
8. Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.
Thomas OG; Haigh TA; Croom-Carter D; Leese A; Van Wijck Y; Douglas MR; Rickinson A; Brooks JM; Taylor GS
PLoS Pathog; 2024 Jun; 20(6):e1012177. PubMed ID: 38843296
[TBL] [Abstract][Full Text] [Related]
9. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
Tschochner M; Leary S; Cooper D; Strautins K; Chopra A; Clark H; Choo L; Dunn D; James I; Carroll WM; Kermode AG; Nolan D
PLoS One; 2016; 11(2):e0147567. PubMed ID: 26849221
[TBL] [Abstract][Full Text] [Related]
10. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy.
Rød BE; Wergeland S; Bjørnevik K; Holmøy T; Ulvestad E; Njølstad G; Myhr KM; Torkildsen Ø
Mult Scler Relat Disord; 2023 Nov; 79():105037. PubMed ID: 37804765
[TBL] [Abstract][Full Text] [Related]
11. Higher frequency of Human herpesvirus-6 (HHV-6) viral DNA simultaneously with low frequency of Epstein-Barr virus (EBV) viral DNA in a cohort of multiple sclerosis patients from Rio de Janeiro, Brazil.
Pereira JG; Leon LAA; de Almeida NAA; Raposo-Vedovi JV; Fontes-Dantas FL; Farinhas JGD; Pereira VCSR; Alves-Leon SV; de Paula VS
Mult Scler Relat Disord; 2023 Aug; 76():104747. PubMed ID: 37267685
[TBL] [Abstract][Full Text] [Related]
12. Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.
Tengvall K; Huang J; Hellström C; Kammer P; Biström M; Ayoglu B; Lima Bomfim I; Stridh P; Butt J; Brenner N; Michel A; Lundberg K; Padyukov L; Lundberg IE; Svenungsson E; Ernberg I; Olafsson S; Dilthey AT; Hillert J; Alfredsson L; Sundström P; Nilsson P; Waterboer T; Olsson T; Kockum I
Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16955-16960. PubMed ID: 31375628
[TBL] [Abstract][Full Text] [Related]
13. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
Lünemann JD; Jelcić I; Roberts S; Lutterotti A; Tackenberg B; Martin R; Münz C
J Exp Med; 2008 Aug; 205(8):1763-73. PubMed ID: 18663124
[TBL] [Abstract][Full Text] [Related]
14. Induction of Proinflammatory Multiple Sclerosis-Associated Retrovirus Envelope Protein by Human Herpesvirus-6A and CD46 Receptor Engagement.
Charvet B; Reynaud JM; Gourru-Lesimple G; Perron H; Marche PN; Horvat B
Front Immunol; 2018; 9():2803. PubMed ID: 30574140
[TBL] [Abstract][Full Text] [Related]
15. Association between human herpesvirus & human endogenous retrovirus and MS onset & progression.
Tao C; Simpson S; Taylor BV; van der Mei I
J Neurol Sci; 2017 Jan; 372():239-249. PubMed ID: 28017222
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
[TBL] [Abstract][Full Text] [Related]
17. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
[TBL] [Abstract][Full Text] [Related]
18. The role of EBV in MS pathogenesis.
Christensen T
Int MS J; 2006 May; 13(2):52-7. PubMed ID: 16635422
[TBL] [Abstract][Full Text] [Related]
19. The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.
Veroni C; Aloisi F
Front Immunol; 2021; 12():665718. PubMed ID: 34305896
[TBL] [Abstract][Full Text] [Related]
20. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
